Age
Range 17-85 years 17-85 years
Median 55 years 55 years
Sex Sex Sex
Female 39 52.7%
Male 35 47.3%
Insect Insect Insect
Bee 16 21.6%
Wasp 58 78.4%
Treatment Treatment Treatment
Beta blockers 3 4.1%
ACE- inhibitors 0 0%
Grade of SR Grade of SR Grade of SR
I 0 0%
II 20 27%
III 46 62.1%
IV 8 10.8%
Reactions during up-dosing (n=74) Reactions during up-dosing (n=74) Reactions during up-dosing (n=74)
No side effects 67 90.5%
Large Local reactions 4 5.4%
Subjective systemic symptoms 3 4.1%
Objective systemic symptoms 0 0%
Total incidence of adverse reactions 7 9.5%
Reactions during maintenance (n=74) Reactions during maintenance (n=74) Reactions during maintenance (n=74)
No side effects 67 90.5%
Large Local reactions 3 4.1%
Subjective systemic symptoms 3 4.1%
Objective systemic symptoms 1 1.4%
Total incidence of adverse reactions 7 9.5%
Field stings Field stings Field stings
During up-dosing During up-dosing During up-dosing
Localised reaction 5 6.8%
Systemic reaction 0 0%
During maintenance During maintenance During maintenance
Localised reaction 15 20.3%
Systemic reaction 0 0%